PAR not yet [Two-Stage / GS Designs]

posted by The Outlaw Torn – Europe, 2011-10-27 13:07 (4558 d 16:21 ago) – Posting: # 7551
Views: 13,969

Hello all,

We provided our protocol to a central European country and this is what they responded about Potvin method C:

“Method C” as proposed in this publication is not acceptable, as type I error is not controlled on the 5% level and alternative methods securing type I error control are available.

They go on to suggest method B because "The authors demonstrate by simulations that the power of this method is only slightly lower than for “Method C”, resulting in comparable mean total number of subjects."

Any comments?

Thanks.

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,653 registered users;
98 visitors (0 registered, 98 guests [including 4 identified bots]).
Forum time: 05:29 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5